Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Falloon, I. R. H. Search for Related Content PubMed Citation Articles by Falloon, I. R. H. Outcome and Process Assessment Quality of Care, Practice Guidelines Rating Scales (Nondiagnostic) Schizophrenia Spectrum Disorders Related Article

The Clinical Strategies Implementation Scale to Measure Implementation of Treatment in Mental Health Services

OBJECTIVE: The authors describe the development of the Clinical Strategies Implementation Scale (CSI), an instrument designed to help providers measure the extent to which evidence-based strategies have been implemented in the treatment of persons with schizophrenia spectrum disorders. METHODS: Nine ordinal scales were devised to measure key aspects of treatment strategies that have been associated with clinical and social recovery from schizophrenia: goal- and problem-oriented assessment, medication strategies, assertive case management, mental health education, caregiver-based problem solving, living skills training, psychological strategies for residual problems, crisis prevention and intervention, and booster sessions. A study of interrater reliability was conducted with 15 trained raters from participating centers in Athens, Auckland, Bonn, Budapest, Gothenburg, and Tokyo who assessed 54 cases. Each treatment strategy was weighted according to its effect size in clinical trials. Correlation analyses were conducted to explore associations between the total CSI score and ratings of clinical, social, and caregiver outcomes each year over four years of continued treatment of 51 patients. RESULTS: Interrater reliability ranged from .93 to .99. Four annual total CSI ratings were significantly correlated with impairment, disability, functioning, work activity, and an index of recovery. Most correlations were stronger in years 3 and 4 than in years 1 and 2. CONCLUSIONS: Reliable and valid assessment of the implementation of evidence-based strategies in clinical practice is feasible. The quality of integrated program implementation may be associated with improved clinical and social recovery from schizophrenic disorders.

Related Article:

December 2005: This Month's Highlights
Psychiatr Serv 2005 56: 1490. [Full Text] [PDF]

This article has been cited by other articles:

				M. V Seeman Olanzapine led to fewer withdrawals than other antipsychotic drugs but increased weight gain, glucose, and lipids Evid. Based Med., June 1, 2006; 11(3): 81 - 81. [Full Text] [PDF]

				G. R. Bond Commentary: Fidelity Measurement and the CSI Psychiatr Serv, December 1, 2005; 56(12): 1591 - 1591. [Full Text] [PDF]

				S. G. Resnick Commentary: Fidelity Measurement, the CSI, and the Current Evidence Base Psychiatr Serv, December 1, 2005; 56(12): 1592 - 1592. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us